ATE235478T1 - Verfahren zur herstellung von citalopram - Google Patents

Verfahren zur herstellung von citalopram

Info

Publication number
ATE235478T1
ATE235478T1 AT99968622T AT99968622T ATE235478T1 AT E235478 T1 ATE235478 T1 AT E235478T1 AT 99968622 T AT99968622 T AT 99968622T AT 99968622 T AT99968622 T AT 99968622T AT E235478 T1 ATE235478 T1 AT E235478T1
Authority
AT
Austria
Prior art keywords
producing citalopram
citalopram
producing
Prior art date
Application number
AT99968622T
Other languages
English (en)
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE235478T1 publication Critical patent/ATE235478T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT99968622T 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram ATE235478T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
ATE235478T1 true ATE235478T1 (de) 2003-04-15

Family

ID=8099035

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99968622T ATE235478T1 (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
AT0904199A AT409961B (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
AT0018401U AT4365U1 (de) 1999-06-25 2001-03-13 Verfahren zur herstellung von citalopram

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT0904199A AT409961B (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
AT0018401U AT4365U1 (de) 1999-06-25 2001-03-13 Verfahren zur herstellung von citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (de)
EP (1) EP1159274B1 (de)
JP (1) JP3447267B2 (de)
KR (1) KR100491368B1 (de)
CN (2) CN1140521C (de)
AR (1) AR020863A1 (de)
AT (3) ATE235478T1 (de)
AU (2) AU1374500A (de)
BG (1) BG65574B1 (de)
BR (1) BR9917368B1 (de)
CA (2) CA2475401A1 (de)
CH (1) CH691305A5 (de)
CZ (1) CZ292198B6 (de)
DE (2) DE69906389T2 (de)
DK (2) DK1159274T3 (de)
EA (1) EA002560B1 (de)
ES (2) ES2189699A1 (de)
FI (1) FI108641B (de)
GB (2) GB2354239B (de)
HK (1) HK1049002B (de)
HU (1) HUP0103235A3 (de)
IL (2) IL145959A0 (de)
IS (1) IS2343B (de)
IT (1) ITMI991581A1 (de)
MX (1) MXPA01010989A (de)
NO (1) NO328542B1 (de)
NZ (1) NZ514979A (de)
PL (1) PL205579B1 (de)
PT (1) PT1159274E (de)
SE (1) SE516690C2 (de)
SI (1) SI1159274T1 (de)
SK (1) SK285813B6 (de)
TR (1) TR200103702T2 (de)
UA (1) UA63034C2 (de)
WO (1) WO2000013648A2 (de)
ZA (1) ZA200108854B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512073A (en) 1998-12-23 2003-10-31 H Method for the preparation of 5-cyanophthalide and citalopram
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PT1173431E (pt) 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
WO2000012044A2 (en) 1999-10-25 2000-03-09 H. Lundbeck A/S Method for the preparation of citalopram
HRP20020344B1 (hr) 1999-10-25 2010-10-31 H. Lundbeck A/S Način priprave citaloprama
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
MXPA02006503A (es) 1999-12-28 2002-12-09 Lundbeck & Co As H Metodo para la preparacion de citalopram.
WO2001049672A1 (en) 1999-12-30 2001-07-12 H. Lundbeck A/S Method for the preparation of citalopram
KR100660802B1 (ko) 2000-01-14 2006-12-26 하. 룬트벡 아크티에 셀스카브 5-시아노프탈리드의 제조 방법
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
WO2001068629A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
CA2402388A1 (en) 2000-03-13 2001-09-20 Hans Petersen Method for the preparation of citalopram
AU2001239213A1 (en) 2000-03-14 2001-09-24 H Lundbeck A/S Method for the preparation of citalopram
SK14812002A3 (sk) * 2000-03-16 2003-02-04 H. Lundbeck A/S Spôsob prípravy 5-kyano-1-(4-fluórfenyl)-1,3-dihydrobenzofuránov a antidepresívny farmaceutický prostriedok
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
BR0106976A (pt) * 2000-07-06 2002-07-23 Lundbeck & Co As H Método para a preparação de citalopram
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
HK1048812B (zh) 2000-12-22 2007-06-01 H‧隆德贝克有限公司 制备纯西酞普兰的方法
AU3920201A (en) * 2000-12-28 2001-07-09 H. Lundbeck A/S Process for the preparation of pure citalopram
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
JP2005500256A (ja) * 2001-03-09 2005-01-06 ランバクシー ラボラトリーズ リミテッド シタロプラム製造方法
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
EP1486492A3 (de) 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. Ein Verfahren zur Hydrogenolyse von [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
ES2285972T1 (es) 2004-08-23 2007-12-01 Sun Pharmaceutical Industries Limited Procedimiento de fabricacion de citalopram y enantiomeros.
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (de) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Verfahren zur Herstellung von Escitalopram
CN114763343A (zh) * 2021-01-14 2022-07-19 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DE69801764T2 (de) * 1997-07-08 2002-07-04 H. Lundbeck A/S, Kobenhavn-Valby Verfahren zur herstellung von citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
WO1998019512A2 (en) * 1997-11-11 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
HU228576B1 (en) * 1998-10-20 2013-04-29 Lundbeck & Co As H Method for the preparation of citalopram
NZ512073A (en) * 1998-12-23 2003-10-31 H Method for the preparation of 5-cyanophthalide and citalopram
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PT1173431E (pt) * 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
WO2000012044A2 (en) * 1999-10-25 2000-03-09 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
HK1048812B (zh) * 2000-12-22 2007-06-01 H‧隆德贝克有限公司 制备纯西酞普兰的方法
AU3920201A (en) * 2000-12-28 2001-07-09 H. Lundbeck A/S Process for the preparation of pure citalopram

Also Published As

Publication number Publication date
IL145959A0 (en) 2002-07-25
FI108641B (fi) 2002-02-28
GB0105182D0 (en) 2001-04-18
SK285813B6 (sk) 2007-08-02
KR20020012204A (ko) 2002-02-15
KR100491368B1 (ko) 2005-05-24
CA2290127A1 (en) 2000-12-25
IS2343B (is) 2008-02-15
ES2194545T3 (es) 2003-11-16
NZ514979A (en) 2004-01-30
DE69906389T2 (de) 2003-10-30
EP1159274A2 (de) 2001-12-05
HUP0103235A2 (hu) 2002-01-28
MXPA01010989A (es) 2002-06-04
GB2357761A (en) 2001-07-04
AR020863A1 (es) 2002-05-29
JP2002526386A (ja) 2002-08-20
BR9917368A (pt) 2002-03-05
GB2354239B (en) 2001-06-06
WO2000013648A8 (en) 2000-05-11
ITMI991581A0 (it) 1999-07-15
GB2354239A (en) 2001-03-21
WO2000013648A3 (en) 2000-07-13
CA2290127C (en) 2005-01-25
IS5861A (is) 2001-02-23
ZA200108854B (en) 2002-08-28
SI1159274T1 (en) 2003-10-31
SK18402001A3 (sk) 2002-06-04
WO2000013648B1 (en) 2001-03-15
EA200101072A1 (ru) 2002-02-28
AU2001100440B4 (en) 2002-01-24
PL205579B1 (pl) 2010-05-31
ATA904199A (de) 2002-05-15
PL346237A1 (en) 2002-01-28
WO2000013648A2 (en) 2000-03-16
US20020077353A1 (en) 2002-06-20
TR200103702T2 (tr) 2002-06-21
SE516690C2 (sv) 2002-02-12
EA002560B1 (ru) 2002-06-27
CZ292198B6 (cs) 2003-08-13
HUP0103235A3 (en) 2003-01-28
CZ2001320A3 (en) 2001-05-16
DK1159274T3 (da) 2003-07-21
FI20010155L (fi) 2001-02-09
BG106191A (en) 2002-08-30
DE69906389D1 (de) 2003-04-30
CN1367786A (zh) 2002-09-04
EP1159274B1 (de) 2003-03-26
SE0100193L (sv) 2001-04-25
AT4365U1 (de) 2001-06-25
SE0100193D0 (sv) 2001-01-24
BR9917368B1 (pt) 2010-02-09
ES2189699A1 (es) 2003-07-01
UA63034C2 (en) 2004-01-15
GB2357761B (en) 2001-09-05
DE19983487C1 (de) 2002-07-25
BG65574B1 (bg) 2009-01-30
NO20010319D0 (no) 2001-01-19
CA2475401A1 (en) 2000-12-25
US20090088469A1 (en) 2009-04-02
IL145959A (en) 2007-07-24
HK1049002B (zh) 2004-12-31
NO20010319L (no) 2001-02-23
PT1159274E (pt) 2003-08-29
CN1140521C (zh) 2004-03-03
CH691305A5 (de) 2001-06-29
ITMI991581A1 (it) 2001-01-15
JP3447267B2 (ja) 2003-09-16
NO328542B1 (no) 2010-03-15
DK200100060A (da) 2001-04-10
AU2001100440A4 (en) 2001-11-01
CN1502616A (zh) 2004-06-09
HK1049002A1 (en) 2003-04-25
GB0101504D0 (en) 2001-03-07
AT409961B (de) 2002-12-27
AU1374500A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
ATE237604T1 (de) Verfahren zur herstellung von citalopram
DE69900891D1 (de) Verfahren zur herstellung von citalopram
ATE235478T1 (de) Verfahren zur herstellung von citalopram
ATE230738T1 (de) Verfahren zur herstellung von citalopram
ATE363476T1 (de) Verfahren zur herstellung von furfural
ATE232524T1 (de) Verfahren zur herstellung von citalopram
ATE222900T1 (de) Verfahren zur herstellung von 5-cyanophthalid
ATE281447T1 (de) Verfahren zur herstellung von citalopram
ATE222899T1 (de) Verfahren zur herstellung von reinem citalopram
ATE236145T1 (de) Verfahren zur herstellung von 5-cyanophthalid
DE69908824D1 (de) Verfahren zur herstellung von bisphenol-a
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
ATE389645T1 (de) Verfahren zur herstellung von citalopram
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
ATE277032T1 (de) Verfahren zur herstellung von citalopram
EP1208106A4 (de) Verfahren zur herstellung von aminopropyl- oder aminoalkyl-unktionalisierten polyalkyl- oder aryl-siloxanen
ATE282031T1 (de) Verfahren zur herstellung von citalopram
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE60004834D1 (de) Verfahren zur herstellung von mikrokapseln
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE50002773D1 (de) Verfahren zur herstellung von hydroxymethylpyridinen
DE60011427D1 (de) Verfahren zur herstellung von 2-pyridylpiperidin-derivaten
DE50004440D1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE60009060D1 (de) Verfahren zur herstellung von 2-pyridylpyridin-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159274

Country of ref document: EP

REN Ceased due to non-payment of the annual fee